Pathogenesis of murine cytomegalovirus infection

Microbes and Infection

Volumn 5, Issue 13, 2003, Pages 1263-1277

  Krmpotic, Astrid ^a   Bubic, Ivan ^a   Polic, Bojan ^a   Lucin, Pero ^a   Jonjic, Stipan ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Immune evasion; Immunosurveillance; Murine cytomegalovirus; Pathogenesis

Indexed keywords

CELL ACTIVITY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSURVEILLANCE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PLASTICITY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5; MAIZE CHLOROTIC MOTTLE VIRUS; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

EID: 0242569404     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2003.09.007     Document Type: Short Survey

References (108)

1. Shanley J.D., Biczak L., Forman S.J. Acute murine cytomegalovirus infection induces lethal hepatitis. J. Infect. Dis. 167:1993;264-269.
2. Katzenstein D.A., Yu G.S., Jordan M.C. Lethal infection with murine cytomegalovirus after early viral replication in the spleen. J. Infect. Dis. 148:1983;406-411.
3. Campbell A.E., Slater J.S., Futch W.S. Murine cytomegalovirus-induced suppression of antigen-specific cytotoxic T lymphocyte maturation. Virology. 173:1989;268-275.
4. Osborn J.E., Blazkovec A.A., Walker D.L. Immunosuppression during acute murine cytomegalovirus infection. J. Immunol. 100:1968;835-844.
5. Trgovcich J., Stimac D., Polic B., Krmpotic A., Pernjak-Pugel E., Tomac J., Hasan M., Wraber B., Jonjic S. Immune responses and cytokine induction in the development of severe hepatitis during acute infections with murine cytomegalovirus. Arch. Virol. 145:2000;2601-2618.
6. Pass R.F. David P.M.H., Knife M. Fields' Virology. 2001;2675-2706 Lippincot Williams & Wilkins.
7. Reddehase M.J., Weiland F., Munch K., Jonjic S., Luske A., Koszinowski U.H. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J. Virol. 55:1985;264-273.
8. Tapper M.L., Rotterdam H.Z., Lerner C.W., Al'Khafaji K., Seitzman P.A. Adrenal necrosis in the acquired immunodeficiency syndrome. Ann. Intern. Med. 100:1984;239-241.
9. Reddehase M.J., Jonjic S., Weiland F., Mutter W., Koszinowski U.H. Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors. J. Virol. 62:1988;1061-1065.
10. Price P., Olver S.D., Silich M., Nador T.Z., Yerkovich S., Wilson S.G. Adrenalitis and the adrenocortical response of resistant and susceptible mice to acute murine cytomegalovirus infection. Eur. J. Clin. Invest. 26:1996;811-819.
11. Mutter W., Reddehase M.J., Busch F.W., Buhring H.J., Koszinowski U.H. Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. J. Exp. Med. 167:1988;1645-1658.
12. Mayer A., Podlech J., Kurz S., Steffens H.P., Maiberger S., Thalmeier K., Angele P., Dreher L., Reddehase M.J. Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes. J. Virol. 71:1997;4589-4598.
13. Busch F.W., Mutter W., Koszinowski U.H., Reddehase M.J. Rescue of myeloid lineage-committed preprogenitor cells from cytomegalovirus-infected bone marrow stroma. J. Virol. 65:1991;981-984.
14. Steffens H.P., Podlech J., Kurz S., Angele P., Dreis D., Reddehase M.J. Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma. J. Virol. 72:1998;5006-5015.
15. Berencsi K., Endresz V., Klurfeld D., Kari L., Kritchevsky D., Gonczol E. Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice. Cell. Adhes. Commun. 5:1998;39-47.
16. Gang D.L., Barrett L.V., Wilson E.J., Rubin R.H., Medearis D.N. Myopericarditis and enhanced dystrophic cardiac calcification in murine cytomegalovirus infection. Am. J. Pathol. 124:1986;207-215.
17. Lenzo J.C., Fairweather D., Cull V., Shellam G.R., James Lawson C.M. Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence. J. Mol. Cell. Cardiol. 34:2002;629-640.
18. Lawson C.M., O'Donoghue H.L., Reed W.D. Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis. Immunology. 75:1992;513-519.
19. Zhang M., Atherton S.S. Apoptosis in the retina during MCMV retinitis in immunosuppressed BALB/c mice. J. Clin. Virol. 25:(Suppl 2):2002;S137-S147.
20. Dix R.D., Podack E.R., Cousins S.W. Loss of the perforin cytotoxic pathway predisposes mice to experimental cytomegalovirus retinitis. J. Virol. 77:2003;3402-3408.
21. Alford C.A., Stagno S., Pass R.F., Britt W.J. Congenital and perinatal cytomegalovirus infections. Rev. Infect. Dis. 12:(Suppl. 7):1990;S745-S753.
22. Fitzgerald N.A., Papadimitriou J.M., Shellam G.R. Cytomegalovirus- induced pneumonitis and myocarditis in newborn mice. A model for perinatal human cytomegalovirus infection. Arch. Virol. 115:1990;75-88.
23. Reddehase M.J., Balthesen M., Rapp M., Jonjic S., Pavic I., Koszinowski U.H. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J. Exp. Med. 179:1994;185-193.
24. Trgovcich J., Pernjak-Pugel E., Tomac J., Koszinowski U.H., Jonjic S. Scholz F.R.M., Doerr W., Cinatl J. Jr. Monographs in Virology. 1998;42-53 Karger, Basel.
25. van den Pol A.N., Reuter J.D., Santarelli J.G. Enhanced cytomegalovirus infection of developing brain independent of the adaptive immune system. J. Virol. 76:2002;8842-8854.
26. Reddehase M.J. Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat. Rev. Immunol. 2:2002;831-844.
27. Koszinowski U.H., Reddehase M.J., Jonjic S. Thomas D.B. Viruses and the Cellular Immune Response. 1993;429-445 Marcel Dekker, London.
28. Biron C.A., Byron K.S., Sullivan J.L. Severe herpesvirus infections in an adolescent without natural killer cells. New Engl. J. Med. 320:1989;1731-1735.
29. Welsh R.M., Brubaker J.O., Vargas-Cortes M., O'Donnell C.L. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. J. Exp. Med. 173:1991;1053-1063.
30. Scalzo A.A. Successful control of viruses by NK cells - a balance of opposing forces. Trends Microbiol. 10:2002;470-474.
31. Scalzo A.A., Fitzgerald N.A., Wallace C.R., Gibbons A.E., Smart Y.C., Burton R.C., Shellam G.R. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J. Immunol. 149:1992;581-589.
32. Scalzo A.A., Fitzgerald N.A., Simmons A., La Vista A.B., Shellam G.R. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med. 171:1990;1469-1483.
33. Lee S.H., Girard S., Macina D., Busa M., Zafer A., Belouchi A., Gros P., Vidal S.M. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28:2001;42-45.
34. Daniels K.A., Devora G., Lai W.C., O'Donnell C.L., Bennett M., Welsh R.M. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 194:2001;29-44.
35. Brown M.G., Dokun A.O., Heusel J.W., Smith H.R., Beckman D.L., Blattenberger E.A., Dubbelde C.E., Stone L.R., Scalzo A.A., Yokoyama W.M. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science. 292:2001;934-937.
36. Bukowski J.F., Woda B.A., Welsh R.M. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52:1984;119-128.
37. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 296:2002;1323-1326.
38. Smith H.R., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., Iizuka K., Furukawa H., Beckman D.L., Pingel J.T., Scalzo A.A., Fremont D.H., Yokoyama W.M. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA. 99:2002;8826-8831.
39. + T cells and NK cells in vivo. Nat. Immunol. 3:2002;529-535.
40. Holtappels R., Thomas D., Podlech J., Reddehase M.J. Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype. J. Virol. 76:2002;151-164.
41. Holtappels R., Podlech J., Grzimek N.K., Thomas D., Pahl-Seibert M.F., Reddehase M.J. Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65). J. Virol. 75:2001;6584-6600.
42. Holtappels R., Thomas D., Podlech J., Geginat G., Steffens H.P., Reddehase M.J. The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells. J. Virol. 74:2000;1871-1884.
43. Riddell S.R., Watanabe K.S., Goodrich J.M., Li C.R., Agha M.E., Greenberg P.D. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 257:1992;238-241.
44. + T-cell memory determined by clonal burst size. Nature. 369:1994;652-654.
45. Kaech S.M., Hemby S., Kersh E., Ahmed R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell. 111:2002;837-851.
46. + T-cell response to readily eliminated and persistent viruses. Philos. Trans. R. Soc. Lond. B Biol. Sci. 355:2000;1093-1101.
47. Holtappels R., Pahl-Seibert M.F., Thomas D., Reddehase M.J. Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs. J. Virol. 74:2000;11495-11503.
48. Podlech J., Holtappels R., Pahl-Seibert M.F., Steffens H.P., Reddehase M.J. Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. J. Virol. 74:2000;7496-7507.
49. Kurz S.K., Reddehase M.J. Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrence. J. Virol. 73:1999;8612-8622.
50. + T cells over time. J. Immunol. 170:2003;2022-2029.
51. Polic B., Jonjic S., Pavic I., Crnkovic I., Zorica I., Hengel H., Lucin P., Koszinowski U.H. Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo. J. Gen. Virol. 77:(Pt 2):1996;217-225.
52. + T lymphocytes. J. Virol. 64:1990;5457-5464.
53. + T lymphocytes. J. Exp. Med. 169:1989;1199-1212.
54. Podlech J., Holtappels R., Wirtz N., Steffens H.P., Reddehase M.J. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation. J. Gen. Virol. 79:(Pt 9):1998;2099-2104.
55. Alterio de Goss M., Holtappels R., Steffens H.P., Podlech J., Angele P., Dreher L., Thomas D., Reddehase M.J. Control of cytomegalovirus in bone marrow transplantation chimeras lacking the prevailing antigen-presenting molecule in recipient tissues rests primarily on recipient-derived CD8 T cells. J. Virol. 72:1998;7733-7744.
56. Hengel H., Lucin P., Jonjic S., Ruppert T., Koszinowski U.H. Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. J. Virol. 68:1994;289-297.
57. Lucin P., Jonjic S., Messerle M., Polic B., Hengel H., Koszinowski U.H. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J. Gen. Virol. 75:(Pt 1):1994;101-110.
58. Pavic I., Polic B., Crnkovic I., Lucin P., Jonjic S., Koszinowski U.H. Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection. J. Gen. Virol. 74:(Pt 10):1993;2215-2223.
59. Lucin P., Pavic I., Polic B., Jonjic S., Koszinowski U.H. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J. Virol. 66:1992;1977-1984.
60. Orange J.S., Salazar-Mather T.P., Opal S.M., Biron C.A. Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection. J. Virol. 71:1997;9248-9258.
61. Hengel H., Esslinger C., Pool J., Goulmy E., Koszinowski U.H. Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J. Gen. Virol. 76:(Pt 12):1995;2987-2997.
62. Heise M.T., Connick M., Virgin H.W.t. Murine cytomegalovirus inhibits interferon gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. J. Exp. Med. 187:1998;1037-1046.
63. Miller D.M., Rahill B.M., Boss J.M., Lairmore M.D., Durbin J.E., Waldman J.W., Sedmak D.D. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187:1998;675-683.
64. Tay C.H., Welsh R.M. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71:1997;267-275.
65. Dalod M., Hamilton T., Salomon R., Salazar-Mather T.P., Henry S.C., Hamilton J.D., Biron C.A. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J. Exp. Med. 197:2003;885-898.
66. Gil M.P., Bohn E., O'Guin A.K., Ramana C.V., Levine B., Stark G.R., Virgin H.W., Schreiber R.D. Biologic consequences of Stat1-independent IFN signaling. Proc. Natl. Acad. Sci. USA. 98:2001;6680-6685.
67. Presti R.M., Pollock J.L., Dal Canto A.J., O'Guin A.K., t. Virgin H.W. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J. Exp. Med. 188:1998;577-588.
68. Polic B., Hengel H., Krmpotic A., Trgovcich J., Pavic I., Luccaronin P., Jonjic S., Koszinowski U.H. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J. Exp. Med. 188:1998;1047-1054.
69. Kurz S., Steffens H.P., Mayer A., Harris J.R., Reddehase M.J. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J. Virol. 71:1997;2980-2987.
70. Pollock J.L., Virgin H.W.t. Latency, without persistence, of murine cytomegalovirus in the spleen and kidney. J. Virol. 69:1995;1762-1768.
71. Hummel M., Zhang Z., Yan S., DePlaen I., Golia P., Varghese T., Thomas G., Abecassis M.I. Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency. J. Virol. 75:2001;4814-4822.
72. Slobedman B., Mocarski E.S. Quantitative analysis of latent human cytomegalovirus. J. Virol. 73:1999;4806-4812.
73. Hahn G., Jores R., Mocarski E.S. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. USA. 95:1998;3937-3942.
74. Kondo K., Kaneshima H., Mocarski E.S. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA. 91:1994;11879-11883.
75. Balthesen M., Dreher L., Lucin P., Reddehase M.J. The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection. J. Gen. Virol. 75:(Pt 9):1994;2329-2336.
76. Balthesen M., Messerle M., Reddehase M.J. Lungs are a major organ site of cytomegalovirus latency and recurrence. J. Virol. 67:1993;5360-5366.
77. Reddehase M.J., Podlech J., Grzimek N.K. Mouse models of cytomegalovirus latency: overview. J. Clin. Virol. 25:(Suppl. 2):2002;S23-S36.
78. Jonjic S., Pavic I., Polic B., Crnkovic I., Lucin P., Koszinowski U.H. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 179:1994;1713-1717.
79. Hummel M., Abecassis M.M. A model for reactivation of CMV from latency. J. Clin. Virol. 25:(Suppl. 2):2002;S123-S136.
80. Koffron A., Varghese T., Hummel M., Yan S., Kaufman D., Fryer J., Leventhal J., Stuart F., Abecassis M. Immunosuppression is not required for reactivation of latent murine cytomegalovirus. Transplant. Proc. 31:1999;1395-1396.
81. Alcami A., Koszinowski U.H. Viral mechanisms of immune evasion. Immunol. Today. 21:2000;447-455.
82. Hengel H., Koszinowski U.H. Interference with antigen processing by viruses. Curr. Opin. Immunol. 9:1997;470-476.
83. Hengel H., Reusch U., Gutermann A., Ziegler H., Jonjic S., Lucin P., Koszinowski U.H. Cytomegaloviral control of MHC class I function in the mouse. Immunol. Rev. 168:1999;167-176.
84. Ziegler H., Thale R., Lucin P., Muranyi W., Flohr T., Hengel H., Farrell H., Rawlinson W., Koszinowski U.H. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity. 6:1997;57-66.
85. Krmpotic A., Messerle M., Crnkovic-Mertens I., Polic B., Jonjic S., Koszinowski U.H. The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo. J. Exp. Med. 190:1999;1285-1296.
86. Reusch U., Muranyi W., Lucin P., Burgert H.G., Hengel H., Koszinowski U.H. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J. 18:1999;1081-1091.
87. Kleijnen M.F., Huppa J.B., Lucin P., Mukherjee S., Farrell H., Campbell A.E., Koszinowski U.H., Hill A.B., Ploegh H.L. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J. 16:1997;685-694.
88. Kavanagh D.G., Gold M.C., Wagner M., Koszinowski U.H., Hill A.B. The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J. Exp. Med. 194:2001;967-978.
89. Wagner M., Gutermann A., Podlech J., Reddehase M.J., Koszinowski U.H. Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J. Exp. Med. 196:2002;805-816.
90. Carayannopoulos L.N., Naidenko O.V., Fremont D.H., Yokoyama W.M. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J. Immunol. 169:2002;4079-4083.
91. Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Riddell S.R., Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2:2001;255-260.
92. Cerwenka A., Bakker A.B., McClanahan T., Wagner J., Wu J., Phillips J.H., Lanier L.L. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 12:2000;721-727.
93. Lodoen M., Ogasawara K., Hamerman J.A., Arase H., Houchins J.P., Mocarski E.S., Lanier L.L. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 197:2003;1245-1253.
94. Diefenbach A., Jamieson A.M., Liu S.D., Shastri N., Raulet D.H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:2000;119-126.
95. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:1999;727-729.
96. Farrell H.E., Vally H., Lynch D.M., Fleming P., Shellam G.R., Scalzo A.A., Davis-Poynter N.J. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature. 386:1997;510-514.
97. Cretney E., Degli-Esposti M.A., Densley E.H., Farrell H.E., Davis-Poynter N.J., Smyth M.J. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J. Exp. Med. 190:1999;435-444.
98. MacDonald M.R., Li X.Y., t. Virgin H.W. Late expression of a beta chemokine homolog by murine cytomegalovirus. J. Virol. 71:1997;1671-1678.
99. Fleming P., Davis-Poynter N., Degli-Esposti M., Densley E., Papadimitriou J., Shellam G., Farrell H. The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity. J. Virol. 73:1999;6800-6809.
100. Davis-Poynter N.J., Lynch D.M., Vally H., Shellam G.R., Rawlinson W.D., Barrell B.G., Farrell H.E. Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus. J. Virol. 71:1997;1521-1529.
101. Thale R., Lucin P., Schneider K., Eggers M., Koszinowski U.H. Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J. Virol. 68:1994;7757-7765.
102. Crnkovic-Mertens I., Messerle M., Milotic I., Szepan U., Kucic N., Krmpotic A., Jonjic S., Koszinowski U.H. Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. J. Virol. 72:1998;1377-1382.
103. Nomura M., Kurita-Taniguchi M., Kondo K., Inoue N., Matsumoto M., Yamanishi K., Okabe M., Seya T. Mechanism of host cell protection from complement in murine cytomegalovirus (CMV) infection: identification of a CMV-responsive element in the CD46 promoter region. Eur. J. Immunol. 32:2002;2954-2964.
104. Miller D.M., Cebulla C.M., Rahill B.M., Sedmak D.D. Cytomegalovirus and transcriptional down-regulation of major histocompatibility complex class II expression. Semin. Immunol. 13:2001;11-18.
105. Skaletskaya A., Bartle L.M., Chittenden T., McCormick A.L., Mocarski E.S., Goldmacher V.S. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. USA. 98:2001;7829-7834.
106. Goldmacher V.S., Bartle L.M., Skaletskaya A., Dionne C.A., Kedersha N.L., Vater C.A., Han J.W., Lutz R.J., Watanabe S., Cahir McFarland E.D., Kieff E.D., Mocarski E.S., Chittenden T. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl. Acad. Sci. USA. 96:1999;12536-12541.
107. Menard C., Wagner M., Ruzsics Z., Holak K., Brune W., Campbell A.E., Koszinowski U.H. Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J. Virol. 77:2003;5557-5570.
108. Brune W., Menard C., Heesemann J., Koszinowski U.H. A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science. 291:2001;303-305.